These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18253762)

  • 1. Development of an experimental hemolytic uremic syndrome in rats.
    Zotta E; Lago N; Ochoa F; Repetto HA; Ibarra C
    Pediatr Nephrol; 2008 Apr; 23(4):559-67. PubMed ID: 18253762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of renal damage and tubular regeneration in pregnant and non-pregnant adult female rats inoculated with a sublethal dose of Shiga toxin 2.
    Fischer Sigel LK; Sánchez DS; Sacerdoti F; Zotta E; Silberstein C
    Microb Pathog; 2024 Jan; 186():106482. PubMed ID: 38086442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal administration of Shiga toxin 2 induced neuronal alterations and reduced the expression levels of aquaporin 1 and aquaporin 4 in rat brain.
    Lucero MS; Mirarchi F; Goldstein J; Silberstein C
    Microb Pathog; 2012 Aug; 53(2):87-94. PubMed ID: 22610042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
    Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
    Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
    Siegler RL; Obrig TG; Pysher TJ; Tesh VL; Denkers ND; Taylor FB
    Pediatr Nephrol; 2003 Feb; 18(2):92-6. PubMed ID: 12579394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157:H7.
    Kim SH; Lee YH; Lee SH; Lee SR; Huh JW; Kim SU; Chang KT
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):427-34. PubMed ID: 22029600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome.
    Ramos MV; Auvynet C; Poupel L; Rodero M; Mejias MP; Panek CA; Vanzulli S; Combadiere C; Palermo M
    Am J Pathol; 2012 Mar; 180(3):1040-1048. PubMed ID: 22203055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease.
    Keepers TR; Psotka MA; Gross LK; Obrig TG
    J Am Soc Nephrol; 2006 Dec; 17(12):3404-14. PubMed ID: 17082244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of stx2 tubular response in a rat experimental model of hemolytic uremic syndrome.
    Ochoa F; Lago NR; Gerhardt E; Ibarra C; Zotta E
    Am J Nephrol; 2010; 32(4):340-6. PubMed ID: 20733289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of interleukin-10 reduces progression of shiga toxin-induced hemolytic uremic syndrome.
    Pineda GE; Rearte B; Todero MF; Bruballa AC; Bernal AM; Fernandez-Brando RJ; Isturiz MA; Zotta E; Alba-Soto CD; Palermo MS; Ramos MV
    Clin Sci (Lond); 2021 Feb; 135(3):575-588. PubMed ID: 33496327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M; Andreoli S
    Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.
    Creydt VP; Miyakawa MF; Martín F; Zotta E; Silberstein C; Ibarra C
    Braz J Med Biol Res; 2004 Jun; 37(6):799-808. PubMed ID: 15264022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
    Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.
    Zoja C; Buelli S; Morigi M
    Pediatr Nephrol; 2019 Mar; 34(3):379-388. PubMed ID: 29214442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.